United BioSource Expands Regulatory Affairs Ca... (m counsel about the impact of thesechang...)

United BioSource Expands Regulatory Affairs Capabilities

Date:2/25/2008

m counsel about the impact of these changes to their programs," says Dr. Ammann.

Dr. LaVonne Lang will join Ammann in a leadership role, serving as Senior Director, Regulatory Affairs. Dr. Lang has 18 years of experience in pharmaceutical development, with 12 years in positions of increasing responsibility in regulatory strategy at Parke-Davis and Pfizer.

The group will conduct cradle-to-grave global strategic planning, manage submission and liaison activities with health authorities and handle medical writing of regulatory documents. As part of its mandate, they will offer services to both emerging and established life science companies.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Eastern and Western Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Mark Ammann, PharmD http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=73619 LaVonne Lang, Dr PH http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=73620

0

GOOD

Page: 1 2
Related biology technology :

1. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
2. United States Patent Office Grants CryoCors Request for Patent Interference
3. United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008
4. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
5. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
6. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
7. Neptune Technologies receives GRAS notification in the United States
8. Essilor: New Acquisitions in the United States and Brazil
9. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
10. Medical Services Begins Working With United States Companies for Distribution of Its Products
11. United Therapeutics Reports Third Quarter 2007 Financial Results

Post Your Comments:

United BioSource Expands Regulatory Affairs Ca...(m counsel about the impact of thesechang...)